Based on the information discussed in preceding sections, we concluded that inhibition of TG2 could be a promising therapeutic target for reversing intrinsic resistance of pancreatic cancer cells to chemotherapeutic drugs. Here, TGM2 is linked to pancreatic neoplasm.